SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 74.78 |
| Enterprise Value ($M) | 41.03 |
| Book Value ($M) | 76.43 |
| Book Value / Share | 2.64 |
| Price / Book | 0.98 |
| NCAV ($M) | 76.22 |
| NCAV / Share | 2.63 |
| Price / NCAV | 0.98 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.91 |
| Return on Assets (ROA) | -0.65 |
| Return on Equity (ROE) | -0.77 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 20.93 |
| Current Ratio | 20.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 80.12 |
| Assets | 80.33 |
| Liabilities | 3.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -74.60 |
| Net Income | -69.63 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -71.20 |
| Cash from Investing | 56.03 |
| Cash from Financing | 25.43 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baker Bros. Advisors Lp | 2.20 | -62.57 | |
| 13D/A | Ra Capital Management, L.p. | 32.00 | 11.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 153,754 | 687,763 | 22.36 | |
| 32,285 | 321,210 | 10.05 | |
| 45,370 | 170,744 | 26.57 | |
| 39,800 | 175,657 | 22.66 | |
| 23,131 | 151,020 | 15.32 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AURA – Aura Biosciences, Inc. | AVBP – ArriVent BioPharma, Inc. |
| AVDL – Avadel Pharmaceuticals plc | AXSM – Axsome Therapeutics, Inc. |
| BCAB – BioAtla, Inc. |
Financial data and stock pages provided by
Fintel.io